Keywords: fda, fast-tracks, oxaliplatin, crc, food, drug, administration

FDA fast-tracks oxaliplatin in CRC

Article | 06 May 2002

Print This

The US Food and Drug Administration has granted a fast-track review toSanofi-Synthelabo for its anticancer drug oxaliplatin as a treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in